Disappointed about how #avct handled the Science Day: A great idea, well hyped upfront, great content... but the average shareholder did not get the full message. I know they had sound issues, but it is all a bit of a nothing-burger, after the hype. Thank God the science is ok
@ZosoGraffiti@bagholder34@coughlin582 If there is one thing i know: i have a good gut-feeling about @coughlin582 . She has been dealt a challenging pack of cards by the previous management. I am ok with dilution, if the end result adds more than equivalent value. #avct
At the end, a nasdaq raise will equally dilute… why would u pay more at a nasdaq ipo per equity share than on the current aim-valuation? Happy to be wrong as a shareholder #AVCT
Very kind of Janet Munro from Novartis to congratualate Avacta on their latest nomination.....#avct Janet Munro 3rd+
Head Program Innovation, Global Drug Development at Novartis
4d
Congrats Avacta team